Alza/McNeil Concerta 420-Rep Sales Force Will Target Peak October Season
Executive Summary
Alza and McNeil Consumer Healthcare are preparing a combined sales force of 420 reps to detail Alza's once-daily methylphenidate treatment Concerta for pediatric attention deficit/hyperactivity disorder.
You may also be interested in...
Alza Concerta To Be Introduced At Discount To Ritalin-SR And Generics
Alza will launch its once-daily methylphenidate Concerta at a discount to Novartis' twice-daily Ritalin-SR as well as generic forms of the sustained-release attention deficit/hyperactivity disorder drug.
Alza Concerta To Be Introduced At Discount To Ritalin-SR And Generics
Alza will launch its once-daily methylphenidate Concerta at a discount to Novartis' twice-daily Ritalin-SR as well as generic forms of the sustained-release attention deficit/hyperactivity disorder drug.
Alza/McNeil Concerta
"Approvable" letter received May 18 for once-daily OROS formulation of methylphenidate for ADD/ADHD. FDA is not requesting additional clinical data, and the companies continue to plan for a fall launch (1"The Pink Sheet" April 24, p. 7). The NDA was submitted July 21, 1999